| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Revenue | $9.1M | +163.5% |
| Cost of Revenue | $4.0M | +66.7% |
| Gross Profit | $5.1M | +376.2% |
| R&D Expense | $5.0M | -1.6% |
| SG&A Expense | $7.4M | -6.5% |
| Operating Income | -$4.2M | +64.4% |
| Pre-tax Income | -$3.6M | +70.7% |
| Net Income | -$3.6M | +70.7% |
| EPS (Basic) | -$0.09 |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.6M | +350.0% |
| Accounts Receivable | $1.3M | +616.1% |
| Inventory | $2.2M | -15.5% |
| Current Assets | $10.2M | +120.8% |
| Total Assets | $10.8M | +100.9% |
| Current Liabilities | $2.3M | +4.1% |
| Total Liabilities | $3.7M | -18.4% |
| Line Item | 2025-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.8M | +74.2% |
| Capital Expenditures | $82K | -32.0% |
| Investing Cash Flow | -$82K | +32.0% |
| Financing Cash Flow | $8.0M | +10.5% |
| Free Cash Flow | -$2.9M | +73.8% |
| +80.4% |
| EPS (Diluted) | -$0.09 | +80.4% |
| Stockholders' Equity |
| $7.1M |
| +760.4% |